Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis

IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Lancet Regional Health-Americas Pub Date : 2025-01-01 DOI:10.1016/j.lana.2024.100963
Klauss Villalva-Serra , Beatriz Barreto-Duarte , Moreno M. Rodrigues , Artur T.L. Queiroz , Leonardo Martinez , Julio Croda , Valeria C. Rolla , Afrânio L. Kritski , Marcelo Cordeiro-Santos , Timothy R. Sterling , Mariana Araújo-Pereira , Bruno B. Andrade
{"title":"Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis","authors":"Klauss Villalva-Serra ,&nbsp;Beatriz Barreto-Duarte ,&nbsp;Moreno M. Rodrigues ,&nbsp;Artur T.L. Queiroz ,&nbsp;Leonardo Martinez ,&nbsp;Julio Croda ,&nbsp;Valeria C. Rolla ,&nbsp;Afrânio L. Kritski ,&nbsp;Marcelo Cordeiro-Santos ,&nbsp;Timothy R. Sterling ,&nbsp;Mariana Araújo-Pereira ,&nbsp;Bruno B. Andrade","doi":"10.1016/j.lana.2024.100963","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Despite government efforts, tuberculosis (TB) remains a major public health threat in Brazil. In 2023, TB incidence was 39.8 cases per 100,000 population, far above the WHO’s target of 6.7 cases per 100,000. Using national-level datasets, we investigated and forecasted the potential impact of proposed public health interventions aimed at reducing TB incidence in Brazil.</div></div><div><h3>Methods</h3><div>Monthly TB surveillance data (January 2018–December 2023) were collected from Brazilian national reporting systems: SINAN-TB (TB cases), SITE-TB (TB drug resistance), and IL-TB (preventive therapy). These data were used to create a multivariable Bayesian Structural Time-Series (BSTS) model, with 5000 Monte-Carlo simulations, which identified key predictors of TB incidence and forecasted these rates from 2024 to 2030 under various scenarios.</div></div><div><h3>Findings</h3><div>Vulnerabilities including incarceration, TB-HIV coinfection and TB-diabetes mellitus, as well as coverages of directly observed therapy (DOT), contact investigation and preventive treatment (TPT) completion rates, were identified as key predictors of TB incidence. Under current trends, we forecasted TB incidence in Brazil to be 42.1 [34.1–49.8] per 100,000 person-years by 2030 (mean [95% prediction intervals]). A scenario considering decreases in TB cases among vulnerable populations resulted in an absolute reduction of −10.6 [−9.4 to −12.0] in projected TB incidence. Additional reductions were seen with increased coverage of DOT, TPT adherence, and contact investigation rates (−14.4 [−13 to −16.2]), and by combining these with efforts to reduce TB cases among vulnerable populations (−23.6 [−26.3 to −41.4]), potentially lowering incidence to 18.5 [7.8–28.4] per 100,000, though still above WHO targets.</div></div><div><h3>Interpretation</h3><div>Our findings demonstrate that interventions focused on enhancing health policies focused on decreasing TB cases among vulnerable populations, such as individuals with TB-HIV coinfection, incarcerated populations, and those with TB-diabetes comorbidity, along with improvements in health management indicators such as DOT implementation, contact investigation coverage, and TPT completion rates, are effective in reducing TB incidence nationwide.</div></div><div><h3>Funding</h3><div><span>Oswaldo Cruz Foundation</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"41 ","pages":"Article 100963"},"PeriodicalIF":7.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697790/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Americas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667193X24002904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Despite government efforts, tuberculosis (TB) remains a major public health threat in Brazil. In 2023, TB incidence was 39.8 cases per 100,000 population, far above the WHO’s target of 6.7 cases per 100,000. Using national-level datasets, we investigated and forecasted the potential impact of proposed public health interventions aimed at reducing TB incidence in Brazil.

Methods

Monthly TB surveillance data (January 2018–December 2023) were collected from Brazilian national reporting systems: SINAN-TB (TB cases), SITE-TB (TB drug resistance), and IL-TB (preventive therapy). These data were used to create a multivariable Bayesian Structural Time-Series (BSTS) model, with 5000 Monte-Carlo simulations, which identified key predictors of TB incidence and forecasted these rates from 2024 to 2030 under various scenarios.

Findings

Vulnerabilities including incarceration, TB-HIV coinfection and TB-diabetes mellitus, as well as coverages of directly observed therapy (DOT), contact investigation and preventive treatment (TPT) completion rates, were identified as key predictors of TB incidence. Under current trends, we forecasted TB incidence in Brazil to be 42.1 [34.1–49.8] per 100,000 person-years by 2030 (mean [95% prediction intervals]). A scenario considering decreases in TB cases among vulnerable populations resulted in an absolute reduction of −10.6 [−9.4 to −12.0] in projected TB incidence. Additional reductions were seen with increased coverage of DOT, TPT adherence, and contact investigation rates (−14.4 [−13 to −16.2]), and by combining these with efforts to reduce TB cases among vulnerable populations (−23.6 [−26.3 to −41.4]), potentially lowering incidence to 18.5 [7.8–28.4] per 100,000, though still above WHO targets.

Interpretation

Our findings demonstrate that interventions focused on enhancing health policies focused on decreasing TB cases among vulnerable populations, such as individuals with TB-HIV coinfection, incarcerated populations, and those with TB-diabetes comorbidity, along with improvements in health management indicators such as DOT implementation, contact investigation coverage, and TPT completion rates, are effective in reducing TB incidence nationwide.

Funding

Oswaldo Cruz Foundation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
战略性公共卫生干预措施对减少巴西结核病发病率的影响:贝叶斯结构时间序列情景分析。
背景:尽管政府做出了努力,结核病仍然是巴西主要的公共卫生威胁。2023年,结核病发病率为每10万人39.8例,远高于世卫组织每10万人6.7例的目标。使用国家级数据集,我们调查并预测了旨在降低巴西结核病发病率的拟议公共卫生干预措施的潜在影响。方法:从巴西国家报告系统中收集每月结核病监测数据(2018年1月至2023年12月):SINAN-TB(结核病病例),SITE-TB(结核病耐药)和IL-TB(预防性治疗)。利用这些数据创建了一个多变量贝叶斯结构时间序列(BSTS)模型,并进行了5000次蒙特卡罗模拟,该模型确定了结核病发病率的关键预测因素,并预测了2024年至2030年不同情景下的结核病发病率。研究结果:包括监禁、结核病-艾滋病合并感染和结核病-糖尿病在内的脆弱性,以及直接观察治疗(DOT)的覆盖率、接触者调查和预防性治疗(TPT)完成率,被确定为结核病发病率的关键预测因素。根据目前的趋势,我们预测到2030年巴西的结核病发病率为每10万人年42.1例[34.1-49.8例](平均[95%预测区间])。考虑到脆弱人群中结核病病例减少的情景导致预测结核病发病率绝对减少-10.6[-9.4至-12.0]。随着dots覆盖率、TPT依从性和接触者调查率的提高(-14.4[-13至-16.2]),以及通过将这些措施与减少弱势人群结核病病例的努力(-23.6[-26.3至-41.4])结合起来,发病率有可能降至每10万人18.5[7.8-28.4],但仍高于世卫组织的目标。解释:我们的研究结果表明,注重加强卫生政策的干预措施,重点是减少弱势人群(如结核病-艾滋病毒合并感染者、监禁人群和结核病-糖尿病合并症患者)的结核病病例,以及改善健康管理指标(如DOT实施、接触者调查覆盖率和TPT完成率),可以有效降低全国结核病发病率。资助:Oswaldo Cruz基金会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.00
自引率
0.00%
发文量
0
期刊介绍: The Lancet Regional Health – Americas, an open-access journal, contributes to The Lancet's global initiative by focusing on health-care quality and access in the Americas. It aims to advance clinical practice and health policy in the region, promoting better health outcomes. The journal publishes high-quality original research advocating change or shedding light on clinical practice and health policy. It welcomes submissions on various regional health topics, including infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, emergency care, health policy, and health equity.
期刊最新文献
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil A global call for family-centered ICU care Performance of the World Health Organization (WHO) severe acute respiratory infection (SARI) case definitions in hospitalized children and youth: cross-sectional study Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study Corrigendum to long-term prescription opioid use following surgery in the US (2017–2022): a population-based study Lancet Reg Health Am. 2024 Dec 4;40:100948
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1